Sudarshan Pharma to Buy 12.5% Stake in Med Therapy Biotech
Sudarshan Pharma plans to acquire 12.5% equity in Med Therapy Biotech. The deal is subject to due diligence and board approvals as per SEBI rules. Source: ScoutQuest
Stock news timeline · SUDARSHAN
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 3 of 3 updates · Newest first
Change the keyword or sentiment above, then click Apply.
Sudarshan Pharma plans to acquire 12.5% equity in Med Therapy Biotech. The deal is subject to due diligence and board approvals as per SEBI rules. Source: ScoutQuest
Sudarshan Pharma to acquire 9.5% stake in MedTherapy Biotech, aiming for US market entry and expansion. Sudarshan Pharma shares surged 369.3% in 3 years, outperforming Sensex with 46% YTD gains. Source: Livemint
Sudarshan Pharma Industries Ltd will hold its 18th Annual General Meeting on Tuesday, 22nd September 2026 via video conferencing. Agenda includes adopting FY 2025-26 financial statements and re-appointing Dr. Anil Ghogare as Non-Executive Director. Source: BSE